Early tuberculosis treatment monitoring by Xpert® MTB/RIF

European Respiratory Journal

Volumn 39, Issue 5, 2012, Pages 1269-1271

  Miotto, Paolo ^a   Bigoni, Sara ^b   Migliori, Giovanni Battista ^c   Matteelli, Alberto ^b   Cirillo, Daniela M ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; PROPIDIUM MONOAZIDE; REAGENT; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ACID FAST BACTERIUM; ANALYTICAL EQUIPMENT; BACTERIAL LOAD; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DNA EXTRACTION; GENE AMPLIFICATION; HUMAN; LETTER; LUNG TUBERCULOSIS; MONITORING; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROCESS OPTIMIZATION; REAL TIME POLYMERASE CHAIN REACTION; SPUTUM CYTODIAGNOSIS; SPUTUM SMEAR; TREATMENT MONITORING;

ANTITUBERCULAR AGENTS; AZIDES; BACTERIAL LOAD; DNA, BACTERIAL; HUMANS; MONITORING, PHYSIOLOGIC; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; PROPIDIUM; SPUTUM; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY;

EID: 84860460748     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00124711     Document Type: Letter

References (9)

1. Ling DI, Zwerling AA, Pai M. GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur Respir J 2008; 32: 1165-1174.
2. Boehme CC, Nicol MP, Nabeta P, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/ RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 2011; 377: 1495-1505.
3. Nocker A, Cheung CY, Camper AK. Comparison of propidium monoazide with ethidium monoazide for differentiation of live vs. dead bacteria by selective removal of DNA from dead cells. J Microbiol Methods 2006; 67: 310-320. (Pubitemid 44402748)
4. Russo C, Tortoli E, Menichella D. Evaluation of the new GenoType Mycobacterium assay for identification of mycobacterial species. J Clin Microbiol 2006; 44: 334-339. (Pubitemid 43222219)
5. World Health Organization. Report of the Tenth Meeting WHO Strategic and Technical Advisory Group for Tuberculosis (STAGTB) 27-29 September 2010. WHO/HTM/TB/2010.18. Geneva, World Health Organization, 2010.
6. Kralik P, Nocker A, Pavlik I. Mycobacterium avium subsp. paratuberculosis viability determination using F57 quantitative PCR in combination with propidium monoazide treatment. J Food Microbiol 2010; 141: Suppl. 1, S80-S86.
7. World Health Organization: Laboratory Services in Tuberculosis Control - Culture Part III. WHO/TB/98.258. Geneva, World Health Organization, 1998.
8. Løvdal T, Hovda MB, Björkblom B, et al. Propidium monoazide combined with real-time quantitative PCR underestimates heatkilled Listeria innocua. J Microbiol Methods 2011; 85: 164-169.
9. Falzon D, Jaramillo E, Schünemann HJ, et al. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J 2011; 38: 516-528.